Brothers Kimberly M, Shanks Robert M Q, Hurlbert Susan, Kowalski Regis P, Tu Elmer Y
The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Eversight Illinois-Bloomington.
JAMA Ophthalmol. 2017 Nov 1;135(11):1184-1190. doi: 10.1001/jamaophthalmol.2017.3797.
Fungal contamination and infection from donor tissues processed for endothelial keratoplasty is a growing concern, prompting analysis of donor tissues after processing.
To determine whether eyebank-processed endothelial keratoplasty tissue is at higher risk of contamination than unprocessed tissue and to model eyebank processing with regard to room temperature exposure on Candida growth in optisol-gentamicin and streptomycin (GS) with and without antifungal supplementation.
DESIGN, SETTING, AND PARTICIPANTS: An examination of the 2013 Eversight Eyebank Study follow-up database for risk factors associated with post-keratoplasty infection identified an increased risk of positive fungal rim culture results in tissue processed for endothelial keratoplasty vs unprocessed tissue. Processing steps at room temperature were hypothesized as a potential risk factor for promotion of fungal growth between these 2 processes. Candida albicans, Candida glabrata, and Candida parapsilosis endophthalmitis isolates were each inoculated into optisol-GS and subjected to 2 different room temperature incubation regimens reflective of current corneal tissue handling protocols.
Eversight Eyebank Study outcomes and measures were follow-up inquiries from 6592 corneal transplants. Efficacy study outcomes and measures were fungal colony-forming units from inoculated vials of optisol-GS taken at 2 different processing temperatures.
Donor rim culture results were 3 times more likely to be positive for fungi in endothelial keratoplasty-processed eyes (1.14%) than for other uses (0.37%) (difference, 0.77%; 95% CI, 0.17-.1.37) (P = .009). In vitro, increased room temperature incubation of optisol-GS increased growth of Candida species over time. The addition of caspofungin and voriconazole decreased growth of Candida in a species-dependent manner.
Detectable Candida growth in donor rim cultures, associated with a higher rate of post keratoplasty infection, is seen in endothelial keratoplasty tissue vs other uses at the time of transplantation, likely owing in part to eyebank preparation processes extending the time of tissue warming. Reduced room temperature incubation and the addition of antifungal agents decreased growth of Candida species in optisol-GS and should be further explored to reduce the risk of infection.
用于内皮角膜移植术的供体组织的真菌污染和感染问题日益受到关注,这促使人们对处理后的供体组织进行分析。
确定眼库处理后的内皮角膜移植组织是否比未处理的组织有更高的污染风险,并模拟眼库处理过程中,在有或没有抗真菌补充剂的情况下,室温暴露对Optisol-庆大霉素和链霉素(GS)中念珠菌生长的影响。
设计、设置和参与者:对2013年Eversight眼库研究随访数据库进行检查,以确定与角膜移植术后感染相关的危险因素,结果发现内皮角膜移植术处理的组织与未处理的组织相比,真菌边缘培养结果呈阳性的风险增加。室温下的处理步骤被认为是这两个过程之间促进真菌生长的潜在危险因素。将白色念珠菌、光滑念珠菌和近平滑念珠菌眼内炎分离株分别接种到Optisol-GS中,并采用两种不同的室温孵育方案,以反映当前角膜组织处理方案。
Eversight眼库研究的结局和指标是对6592例角膜移植患者的随访询问。疗效研究的结局和指标是在两种不同处理温度下,接种Optisol-GS小瓶中的真菌菌落形成单位。
内皮角膜移植术处理的眼中,供体边缘培养结果真菌呈阳性的可能性是其他用途眼的3倍(1.14%)(差异为0.77%;95%CI,0.17%-1.37%)(P = 0.009)。在体外,Optisol-GS在室温下孵育时间延长,念珠菌属的生长会增加。添加卡泊芬净和伏立康唑会以种属依赖的方式降低念珠菌的生长。
在内皮角膜移植组织与移植时的其他用途组织相比,供体边缘培养中可检测到念珠菌生长,这与角膜移植术后较高的感染率相关,这可能部分归因于眼库准备过程延长了组织升温时间。减少室温孵育时间并添加抗真菌剂可降低Optisol-GS中念珠菌属的生长,应进一步探索以降低感染风险。